NEW YORK (Genomeweb) – Everything Genetic will distribute and market OncoDNA's solutions in the UK under an agreement announced today.
All of OncoDNA's services are now available for clinical use, it said, adding oncologists and patients will be able to access its molecular profiling solutions that combine liquid and solid biopsy assays.
Financial and other terms were not disclosed.
OncoDNA, based in Belgium, recently inked distribution deals covering Morocco and Belarus. Last month, it said that it will help perform patient stratification in a Phase II precision medicine study in head and neck cancer being run by the European Organization for Research and Treatment of Cancer.